| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 99.61B | 98.68B | 98.98B | 93.28B | 91.47B | 82.48B |
| Gross Profit | 26.51B | 26.48B | 25.02B | 23.95B | 22.57B | 21.72B |
| EBITDA | 8.97B | 9.17B | 8.75B | 8.47B | 7.73B | 7.03B |
| Net Income | 4.58B | 4.66B | 4.78B | 4.50B | 3.94B | 4.15B |
Balance Sheet | ||||||
| Total Assets | 122.80B | 123.38B | 122.99B | 120.18B | 107.51B | 98.40B |
| Cash, Cash Equivalents and Short-Term Investments | 29.48B | 27.54B | 29.98B | 29.22B | 26.26B | 23.97B |
| Total Debt | 11.65B | 6.92B | 11.59B | 11.52B | 10.07B | 5.95B |
| Total Liabilities | 41.68B | 38.38B | 43.30B | 43.73B | 38.44B | 32.50B |
| Stockholders Equity | 80.34B | 84.17B | 78.92B | 75.72B | 68.41B | 65.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.58B | 2.26B | 2.69B | -1.25B | 1.52B |
| Operating Cash Flow | 0.00 | 8.00B | 6.42B | 8.10B | 5.65B | 5.80B |
| Investing Cash Flow | 0.00 | -4.45B | -5.09B | -5.79B | -6.67B | -3.82B |
| Financing Cash Flow | 0.00 | -6.34B | -1.09B | 391.00M | 3.23B | 583.28M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥187.27B | 13.86 | 4.41% | 3.80% | -4.32% | 27.07% | |
70 Outperform | ¥198.09B | 10.74 | ― | 4.09% | -2.00% | 23.48% | |
69 Neutral | ¥60.78B | 13.04 | ― | 2.88% | -0.31% | -2.59% | |
64 Neutral | ¥2.68T | 21.61 | ― | 1.11% | 3.94% | 25.43% | |
63 Neutral | ¥13.95B | 10.79 | ― | 3.89% | -0.65% | -0.09% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | ¥385.81B | 24.59 | -4.00% | 3.71% | -4.00% | ― |